TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33084088

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor blockade (using exendin9-39) before surgery
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: RYGB
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor blockade after RYGB
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Default mode and right frontoparietal network connectivity changes after RYGB
Number of subjects: 9
Study: 32091596

Group type: EXPERIMENTAL
Intervention: 3-dose bivalent HPV vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1-dose bivalent HPV vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unvaccinated women
Number of subjects: 0
Study: 35182925

Group type: EXPERIMENTAL
Intervention: Gemcitabine-based chemotherapy
Number of subjects: 419

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 419
Study: 34078367

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 32192811

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01 co-administered with YF and MR vaccines
Number of subjects: 709

Group type: COMPARATOR
Intervention: RTS,S/AS01 alone
Number of subjects: 709

Group type: COMPARATOR
Intervention: YF and MR vaccines alone
Number of subjects: 709
Study: 36431088

Group type: EXPERIMENTAL
Intervention: AI-assisted personalized diet based on microbiome analysis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional treatment (sodium picosulfate plus laxatives, enemas, increased fiber, and fluid intake)
Number of subjects: 50
Study: 33046141

Group type: EXPERIMENTAL
Intervention: Glyceride formulation of EPA + DHA (2.8 g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ethyl ester formulation of EPA + DHA (2.8 g)
Number of subjects: 20
Study: 34595695

Group type: EXPERIMENTAL
Intervention: Entertainment-education video
Number of subjects: 111

Group type: COMPARATOR
Intervention: Informational brochure (flyer)
Number of subjects: 111
Study: 32083443

Group type: EXPERIMENTAL
Intervention: 12-session cardiac rehabilitation
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 24-session cardiac rehabilitation
Number of subjects: 112
Study: 36454119

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 24477

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting CSS
Number of subjects: 24477
Study: 33359437

Group type: EXPERIMENTAL
Intervention: Duodenal mucosal resurfacing (DMR) combined with glucagon-like peptide-1 receptor agonist (GLP-1RA) (liraglutide) and lifestyle counseling
Number of subjects: 16
Study: 36192223

Group type: EXPERIMENTAL
Intervention: Mobile application (app) for oral hygiene guidance and motivation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard oral hygiene (SOH) instructions
Number of subjects: 8
Study: 33909330

Group type: EXPERIMENTAL
Intervention: Spironolactone (SPL) 200 mg/day
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 32500725

Group type: EXPERIMENTAL
Intervention: Immediate switch from amiodarone to dronedarone
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: 2-week washout before switching to dronedarone
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Dronedarone pharmacokinetics
Number of subjects: 284

Group type: COMPARATOR
Intervention: Amiodarone (control group)
Number of subjects: 284
Study: 34399650

Group type: EXPERIMENTAL
Intervention: Remodeled bicycle pedal training for 6 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nontraining group (FAI-NT)
Number of subjects: 26
Study: 33445588

Group type: EXPERIMENTAL
Intervention: Somatosensory rehabilitation in addition to standard physical therapy for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard physical therapy for 8 weeks
Number of subjects: 30
Study: 35787730

Group type: EXPERIMENTAL
Intervention: Mandate (N = 229)
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Negative monetary incentive (N = 244)
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Positive monetary incentive (N = 228)
Number of subjects: 929

Group type: COMPARATOR
Intervention: Information provision (N = 228)
Number of subjects: 929
Study: 32193981

Group type: EXPERIMENTAL
Intervention: LIVE‐LiFE intervention (strength and balance training integrated into daily habits, 8 visits over 12 weeks, plus US$500 in home safety changes, vision contrast screening, and medication recommendations)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: LIVE‐LiFE intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control condition (fall prevention materials and individualized fall risk summary)
Number of subjects: 37
Study: 34673998

Group type: EXPERIMENTAL
Intervention: Hyperosmolar dextrose injection (12.5%)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 70
Study: 32746140

Group type: EXPERIMENTAL
Intervention: Self-supervised feature learning method utilizing multi-modal data (including FFA modality)
Number of subjects: 0
Study: 35759333

Group type: EXPERIMENTAL
Intervention: myDEx intervention (6-session content over 3 months)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: myDEx intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Attention-control arm
Number of subjects: 180
Study: 34257675

Group type: EXPERIMENTAL
Intervention: ω‐3FA concentrate 2000 mg (Group A)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: ω‐3FA concentrate 2000 mg + PCC200 mcg (Group B)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: ω‐3FA concentrate 2000 mg + PCC400 mcg (Group C)
Number of subjects: 58
Study: 35193041

Group type: EXPERIMENTAL
Intervention: Deficit on visual capacity
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Persistent impairment of locomotor capacity
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Persistent impairment of psychological capacity
Number of subjects: 693
Study: 33824980

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training at home on a tablet device (N=24)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (N=21, completed ≥10 training sessions)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Waitlist group (N=23)
Number of subjects: 47
Study: 35164864

Group type: EXPERIMENTAL
Intervention: H. pylori eradication treatment for one week
Number of subjects: 5355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5355
Study: 34623318

Group type: EXPERIMENTAL
Intervention: SMS program (n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Weekly text assessment (n=50)
Number of subjects: 100
Study: 33238431

Group type: EXPERIMENTAL
Intervention: Lacto-Ovo-Vegetarian Diet (VD)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Isocaloric Meat Diet (MD)
Number of subjects: 31
Study: 33098496

Group type: EXPERIMENTAL
Intervention: Natural radionuclide concentrations (226Ra, 232Th, 40K)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Radium equivalent activity (Raeq), hazard indices (Hex, Hin), radioactivity level indices (Iϒr, Iα, AUI)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Indoor and outdoor dose rates (Ḋ), age‐dependent annual effective doses (AED), organ‐specific doses, lifetime attributable cancer risk
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Radon/thoron exhalation rate
Number of subjects: 26
Study: 33572955

Group type: EXPERIMENTAL
Intervention: Awareness-raising interventions tailored to reduce stigmatising beliefs and attitudes among primary care professionals (PC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Awareness-raising interventions tailored to reduce stigmatising beliefs and attitudes among mental health professionals (MH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33094958

Group type: COMPARATOR
Intervention: Empirical therapy (triple therapy with esomeprazole, amoxicillin, and clarithromycin for 10 days)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Tailored therapy (triple or quadruple therapy with esomeprazole, metronidazole, tetracycline, and bismuth for 10 days based on genotype markers of resistance)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Tailored therapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Empirical therapy
Number of subjects: 72
Study: 34762351

Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg daily intravenously
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (standard COVID-19 pharmacotherapy)
Number of subjects: 30
Study: 34032829

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 20% hypertonic saline solution plus standard care
Number of subjects: 370

Group type: COMPARATOR
Intervention: Standard care alone (control)
Number of subjects: 370
Study: 32398077

Group type: EXPERIMENTAL
Intervention: Postpartum family planning intervention including counseling on PPFP and PPIUD insertion during delivery services
Number of subjects: 15264

Group type: EXPERIMENTAL
Intervention: Postpartum family planning intervention with universal counseling
Number of subjects: 15264
Study: 35762095

Group type: EXPERIMENTAL
Intervention: OHI (electric toothbrush and intensive oral hygiene manoeuvre adaptation)
Number of subjects: 140

Group type: COMPARATOR
Intervention: no-OHI (routine habits)
Number of subjects: 140
Study: 34199448

Group type: EXPERIMENTAL
Intervention: MaP-BC intervention (n = 18)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (standard care only, n = 17)
Number of subjects: 35
Study: 32207659

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy defibrillators (CRT-D)
Number of subjects: 12638

Group type: COMPARATOR
Intervention: Optimal pharmacologic therapy (OPT)
Number of subjects: 12638

Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillators (ICD)
Number of subjects: 12638

Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy pacemakers (CRT-P)
Number of subjects: 12638
Study: 35573335

Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training (BPT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 30
Study: 33097422

Group type: EXPERIMENTAL
Intervention: Continuous antibiotic prophylaxis (CAP)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group without CAP
Number of subjects: 105
Study: 36456409

Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication reconciliation (MC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32928024

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Nicotine withdrawal (24 h)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Ad libitum smoking
Number of subjects: 149
Study: 34208162

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 524
Study: 33143640

Group type: EXPERIMENTAL
Intervention: Cerebrolysin (30 ml/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 50
Study: 33811460

Group type: EXPERIMENTAL
Intervention: Nomogram based on radiologic findings
Number of subjects: 3708

Group type: COMPARATOR
Intervention: American nomogram
Number of subjects: 3708

Group type: COMPARATOR
Intervention: Korean/Japanese nomogram
Number of subjects: 3708
Study: 33372320

Group type: EXPERIMENTAL
Intervention: 12-week aerobic exercise intervention
Number of subjects: 31
Study: 34593990

Group type: EXPERIMENTAL
Intervention: AdVEGF-D gene therapy (GT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 33818845

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for insomnia (CBT‐I)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 46
Study: 36163030

Group type: EXPERIMENTAL
Intervention: Culturally tailored cognitive-behavioural intervention (5 sessions, 30-35 min each, weekly)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 34297333

Group type: EXPERIMENTAL
Intervention: FRAMES Group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both Groups
Number of subjects: 70
Study: 32326354

Group type: COMPARATOR
Intervention: Control (CON; 19 °C, 8h sleep opportunity)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Hot (HOT; 33 °C, 8h sleep opportunity)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Hot and Sleep Restricted (HOT + SR; 33 °C, 4‐h sleep opportunity)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sleep Restricted (SR; 19 °C, 4‐h sleep opportunity)
Number of subjects: 66
Study: 35465859

Group type: EXPERIMENTAL
Intervention: Video-based monitoring systems (VMSs) for auditing hand hygiene compliance
Number of subjects: 111
Study: 32357364

Group type: EXPERIMENTAL
Intervention: PROMPT intervention (45 min, two times a week for 10 weeks)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: PROMPT intervention
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (waitlisted, home training instructions)
Number of subjects: 49
Study: 33812334

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel/Gemcitabine (NAB-P/G)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Gemcitabine (G)
Number of subjects: 124
Study: 33093816

Group type: EXPERIMENTAL
Intervention: Transcatheter closure under transthoracic echocardiography (TTE) guidance
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fluoroscopy guidance
Number of subjects: 100
Study: 33514817

Group type: EXPERIMENTAL
Intervention: Multilayer multimodal detection and prediction model using random forest (RF) classifier
Number of subjects: 1048
Study: 35787730

Group type: EXPERIMENTAL
Intervention: Mandate (N=229)
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Negative monetary incentive (N=244)
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Positive monetary incentive (N=228)
Number of subjects: 929

Group type: COMPARATOR
Intervention: Information provision (N=228)
Number of subjects: 929
Study: 34196693

Group type: EXPERIMENTAL
Intervention: Pembrolizumab arm (PA)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control arm (CA)
Number of subjects: 185
Study: 35743466

Group type: EXPERIMENTAL
Intervention: Virtual supervised exercise program throughout pregnancy, 3 days per week
Number of subjects: 157
Study: 32843098

Group type: EXPERIMENTAL
Intervention: High dose dexamethasone (16 mg/24 hours for 5 days followed by 8 mg/24 hours for 5 days) + standard ICU care
Number of subjects: 284

Group type: COMPARATOR
Intervention: Standard ICU care
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: High dose dexamethasone + standard ICU care
Number of subjects: 284
Study: 35550062

Group type: EXPERIMENTAL
Intervention: EXALT Model B Regular
Number of subjects: 15

Group type: COMPARATOR
Intervention: aScope 4 Large
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: EXALT Model B
Number of subjects: 15
Study: 32198423

Group type: EXPERIMENTAL
Intervention: Exergame intervention (24 weeks, 120 min/week, 2 sessions of 60 min each)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 50
Study: 35908203

Group type: EXPERIMENTAL
Intervention: Ultrasound measured thickness of the fascia
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ultrasound measured thickness of the fat pad
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Microvascular volume (MV) by contrast-enhanced ultrasound
Number of subjects: 90
Study: 34599167

Group type: EXPERIMENTAL
Intervention: Short educational video during four well-child visits with pediatrician
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Twelve home visits with feedback based on daily interactions with their child
Number of subjects: 0
Study: 32583948

Group type: EXPERIMENTAL
Intervention: Daratumumab in combination with lenalidomide and dexamethasone (POLLUX)
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Daratumumab in combination with bortezomib and dexamethasone (CASTOR)
Number of subjects: 1067

Group type: COMPARATOR
Intervention: Active controls (lenalidomide and dexamethasone, bortezomib and dexamethasone)
Number of subjects: 1067
Study: 33581737

Group type: EXPERIMENTAL
Intervention: Canagliflozin (CG) 100 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 33154545

Group type: EXPERIMENTAL
Intervention: Expectation of deferring gratification based on a speaker's promise
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Expectation of instant gratification when no promise was made
Number of subjects: 32
Study: 34262668

Group type: EXPERIMENTAL
Intervention: Group Problem Management Plus (GroupPM+)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Enhanced treatment-as-usual
Number of subjects: 35
Study: 33049696

Group type: EXPERIMENTAL
Intervention: Smart glasses group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonglasses group
Number of subjects: 20
Study: 36214938

Group type: EXPERIMENTAL
Intervention: Removable prosthesis and individualized swallowing function training
Number of subjects: 16
Study: 33752174

Group type: EXPERIMENTAL
Intervention: Newly diagnosed diabetes mellitus-related hyperglycemia (NDDM-RH)
Number of subjects: 3026

Group type: EXPERIMENTAL
Intervention: Stress hyperglycemia
Number of subjects: 3026

Group type: COMPARATOR
Intervention: Previously diagnosed diabetes mellitus (PDDM)
Number of subjects: 3026
Study: 32034079

Group type: EXPERIMENTAL
Intervention: Vaccination intervention, details not specified
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35148573

Group type: EXPERIMENTAL
Intervention: HS016
Number of subjects: 502

Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 502
Study: 34100769

Group type: EXPERIMENTAL
Intervention: RealRisks web-based decision aid (DA)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard educational materials
Number of subjects: 300
Study: 35617272

Group type: EXPERIMENTAL
Intervention: Blended web-based rehabilitation program (6-week duration) consisting of exercise and advice material enhanced with outdoor structured physical activity.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Outdoor structured physical activity alone (control group).
Number of subjects: 56
Study: 33579842

Group type: EXPERIMENTAL
Intervention: Caregiver strain
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Caregiver age
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Cognitive impairment of the person with dementia
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Depression of the person with dementia
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Anxiety of the person with dementia
Number of subjects: 301
Study: 36367616

Group type: EXPERIMENTAL
Intervention: α‐rTMS (19 sessions over 4 weeks)
Number of subjects: 28
Study: 33983794

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan 97/103mg twice daily
Number of subjects: 93

Group type: COMPARATOR
Intervention: Valsartan 160mg twice daily
Number of subjects: 93
Study: 33415867

Group type: EXPERIMENTAL
Intervention: Acupoint thread-embedding therapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Acupuncture therapy
Number of subjects: 68
Study: 35534640

Group type: EXPERIMENTAL
Intervention: Systemic arterial pulsatility index (SAPi)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 142
Study: 34261541

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg Q4W
Number of subjects: 1120

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg Q8W
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1120
Study: 35164841

Group type: EXPERIMENTAL
Intervention: Tailored, multi-faceted intervention based on the guideline (interactive educational symposium plus academic detailing)
Number of subjects: 1358

Group type: EXPERIMENTAL
Intervention: Tailored, multi-faceted intervention based on the guideline
Number of subjects: 1358

Group type: COMPARATOR
Intervention: Passive dissemination of the guideline (control group)
Number of subjects: 1358
Study: 33174080

Group type: EXPERIMENTAL
Intervention: Benefits presented before risks (BR)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Risks presented before benefits (RB)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: All attributes randomised (RN)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Deterministic attribute grouping
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Dominance and stability tests
Number of subjects: 156
Study: 36013132

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite‐based toothpaste plus mouthwash (Trial group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Toothpaste alone (Control Group)
Number of subjects: 0
Study: 32207705

Group type: EXPERIMENTAL
Intervention: Complex biologically active food supplement Osteomed forte prescribed for 12 months (SG1 and SG2)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Complex biologically active food supplement Osteomed forte prescribed for 12 months (SG1)
Number of subjects: 119

Group type: COMPARATOR
Intervention: No intervention (SG3)
Number of subjects: 119
Study: 34863038

Group type: EXPERIMENTAL
Intervention: LY2409021 (100 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34054053

Group type: EXPERIMENTAL
Intervention: Combined DASH diet and low sodium intake
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Potassium‐rich DASH diet
Number of subjects: 343

Group type: COMPARATOR
Intervention: Control diet and high sodium intake
Number of subjects: 343
Study: 35871810

Group type: EXPERIMENTAL
Intervention: Immobilisation of torus fractures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32135429

Group type: EXPERIMENTAL
Intervention: Buprenorphine and naloxone treatment
Number of subjects: 0
Study: 34747558

Group type: EXPERIMENTAL
Intervention: Warmed, humidified CO2 (WHCO2)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 39
Study: 32881071

Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST) + Treatment as Usual (TAU) (n = 23)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) (n = 24)
Number of subjects: 47
Study: 33431780

Group type: EXPERIMENTAL
Intervention: Support program for dietary behavior change
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 34501831

Group type: EXPERIMENTAL
Intervention: Resisted sled-based training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional unresisted sprint training
Number of subjects: 0